Insights from 2024 ESGO Annual Meeting


 

ESGO 2024 Insights: "IMAGYN-050 Trial - Benefit From Atezolizumab in Pts With a Poor Prognostic Ovarian Cancer in 1L Setting"

82 views
March 22, 2024
Comments 0
Login to view comments. Click here to Login